Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 3, 2013, Pages

  Raison, Denis ^a,b   Coquard, Catherine ^a,b   Hochane, Mazène ^a,b   Steger, Jacques ^a,b   Massfelder, Thierry ^a,b   Moulin, Bruno ^b,c   Karaplis, Andrew C ^d   Metzger, Daniel ^b,e   Chambon, Pierre ^b   Helwig, Jean Jacques ^a,b   Barthelmebs, Mariette ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c HÔPITAL CIVIL   (France)

^d MCGILL UNIVERSITY   (Canada)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Blood pressure; Parathyroid hormone related protein; Renal hemody namics; Saline volume expansion

Indexed keywords

CALCIUM; CREATININE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE; RENIN; SODIUM; SODIUM CHLORIDE; TAMOXIFEN;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CREATININE CLEARANCE; DIURESIS; FLUID INTAKE; FOOD INTAKE; GENE SILENCING; GENE TARGETING; GLOMERULUS FILTRATION RATE; HEART RATE; HOMEOSTASIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MOUSE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN RELEASE; SMOOTH MUSCLE FIBER; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE;

EID: 84881017066     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00503.2012     Document Type: Article

References (42)

1. Burton DW, Brandt DW, Deftos LJ. Parathyroid hormone-related protein in the cardiovascular system. Endocrinology 135: 253-261, 1994.
2. Cervenka L, Mitchell KD, Navar LG. Renal function in mice: effects of volume expansion and angiotensin II. J Am Soc Nephrol 10: 2631-2636, 1999.
3. Champy MF, Selloum M, Piard L, Zeitler V, Caradec C, Chambon P, Auwerx J. Mouse functional genomics requires standardization of mouse handling and housing conditions. Mamm Genome 15: 768-783, 2004.
4. Clemens TL, Cormier S, Eichinger A, Endlich K, Fiaschi-Taesch N, Fischer E, Friedman PA, Karaplis AC, Massfelder T, Rossert J, Schluter KD, Silve C, Stewart AF, Takane K, Helwig JJ. Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol 134: 1113-1136, 2001.
5. DiPette DJ, Christenson W, Nickols MA, Nickols GA. Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology 130: 2045-2051, 1992.
6. Endlich K, Massfelder T, Helwig JJ, Steinhausen M. Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney. J Physiol 483: 481-490, 1995.
7. Figtree GA, Webb CM, Collins P. Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism. J Pharmacol Exp Ther 295: 519-523, 2000.
8. Fritsch S, Lindner V, Welsch S, Massfelder T, Grima M, Rothhut S, Barthelmebs M, Helwig JJ. Intravenous delivery of PTH/PTHrP type 1 receptor cDNA to rats decreases heart rate, blood pressure, renal tone, renin angiotensin system, and stress-induced cardiovascular responses. J Am Soc Nephrol 15: 2588-2600, 2004.
9. Griol-Charhbili V, Sabbah L, Colucci J, Vincent MP, Baudrie V, Laude D, Elghozi JL, Bruneval P, Picard N, Meneton P, Alhenc-Gelas F, Richer C. Tissue kallikrein deficiency and renovascular hypertension in the mouse. Am J Physiol Regul Integr Comp Physiol 296: R1385-R1391, 2009.
10. He B, Deckelbaum RA, Miao D, Lipman ML, Pollak M, Goltzman D, Karaplis AC. Tissue-specific targeting of the pthrp gene: the generation of mice with floxed alleles. Endocrinology 142: 2070-2077, 2001.
11. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8: 277-289, 1994.
12. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LH, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273: 663-666, 1996.
13. Maeda S, Sutliff RL, Qian J, Lorenz JN, Wang J, Tang H, Nakayama T, Weber C, Witte D, Strauch AR, Paul RJ, Fagin JA, Clemens TL. Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology 140: 1815-1825, 1999.
14. Mark CJ, Tatchum-Talom R, Martin DS, Eyster KM. Effects of estrogens and selective estrogen receptor modulators on vascular reactivity in the perfused mesenteric vascular bed. Am J Physiol Regul Integr Comp Physiol 293: R1969-R1975, 2007.
15. Marshall EK Jr., Litchfield JT. The determination of sulfanilamide. Science 88: 85-86, 1938.
16. Martin TJ, Moseley JM, Williams ED. Parathyroid hormone-related protein: hormone and cytokine. J Endocrinol 154 Suppl: S23-S37, 1997.
17. Massfelder T, Parekh N, Endlich K, Saussine C, Steinhausen M, Helwig JJ. Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthe-tized rat. Br J Pharmacol 118: 1995-2000, 1996.
18. Massfelder T, Stewart AF, Endlich K, Soifer N, Judes C, Helwig JJ. Parathyroid hormone-related protein detection and interaction with NO and cyclic AMP in the renovascular system. Kidney Int 50: 1591-1603, 1996.
19. Massfelder T, Taesch N, Fritsch S, Eichinger A, Barthelmebs M, Stewart AF, Helwig JJ. Type 1 parathyroid hormone receptor expression level modulates renal tone and plasma renin activity in spontaneously hypertensive rat. J Am Soc Nephrol 13: 639-648, 2002.
20. Monego G, Arena V, Pasquini S, Stigliano E, Fiaccavento R, Leone O, Arpesella G, Potena L, Ranelletti FO, Di Nardo P, Capelli A. Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes. Basic Res Cardiol 104: 427-434, 2009.
21. Musso MJ, Barthelmebs M, Imbs JL, Plante M, Bollack C, Helwig JJ. The vasodilator action of parathyroid hormone fragments on isolated perfused rat kidney. Naunyn Schmiedebergs Arch Pharmacol 340: 246-251, 1989.
22. Musso MJ, Plante M, Judes C, Barthelmebs M, Helwig JJ. Renal vasodilatation and microvessel adenylate cyclase stimulation by synthetic parathyroid hormone-like protein fragments. Eur J Pharmacol 174: 139-151, 1989.
23. Nickols GA, Metz MA, Cline WH. Endothelium-independent linkage of parathyroid hormone receptors of rat vascular tissue with increased aden-osine 3=,5=-monophosphate and relaxation of vascular smooth muscle. Endocrinology 119: 349-356, 1986.
24. Nickols GA, Nana AD, Nickols MA, DiPette DJ, Asimakis GK. Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor. Endocrinology 125: 834-841, 1989.
25. Noonan WT, Qian J, Stuart WD, Clemens TL, Lorenz JN. Altered renal hemodynamics in mice overexpressing the parathyroid hormone (PTH)/PTH-related peptide type 1 receptor in smooth muscle. Endocrinology 144: 4931-4938, 2003.
26. Okano K, Wu S, Huang X, Pirola CJ, Juppner H, Abou-Samra AB, Segre GV, Iwasaki K, Fagin JA, Clemens TL. Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonu-cleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II and PTHrP. Endocrinology 135: 1093-1099, 1994.
27. Pill J, Issaeva O, Woderer S, Sadick M, Kranzlin B, Fiedler F, Klotzer HM, Kramer U, Gretz N. Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements. Naunyn Schmiedebergs Arch Pharmacol 373: 204-211, 2006.
28. Qian J, Lorenz JN, Maeda S, Sutliff RL, Weber C, Nakayama T, Colbert MC, Paul RJ, Fagin JA, Clemens TL. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology 140: 1826-1833, 1999.
29. Roca-Cusachs A, DiPette DJ, Nickols GA. Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther 256: 110-118, 1991.
30. Saussine C, Judes C, Massfelder T, Musso MJ, Simeoni U, Hanne-douche T, Helwig JJ. Stimulatory action of parathyroid hormone on renin secretion in vitro: a study using isolated rat kidney, isolated rabbit glomeruli and superfused dispersed rat juxtaglomerular cells. Clin Sci (Lond) 84: 11-19, 1993.
31. Saussine C, Massfelder T, Parnin F, Judes C, Simeoni U, Helwig JJ. Renin stimulating properties of parathyroid hormone-related peptide in the isolated perfused rat kidney. Kidney Int 44: 764-773, 1993.
32. Schluter K, Katzer C, Frischkopf K, Wenzel S, Taimor G, Piper HM. Expression, release, and biological activity of parathyroid hormone-related peptide from coronary endothelial cells. Circ Res 86: 946-951, 2000.
33. Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37: 34-41, 1998.
34. Schordan E, Welsch S, Rothhut S, Lambert A, Barthelmebs M, Helwig JJ, Massfelder T. Role of parathyroid hormone-related protein in the regulation of stretch-induced renal vascular smooth muscle cell pro-liferation. J Am Soc Nephrol 15: 3016-3025, 2004.
35. Soegiarto DW, Kiachopoulos S, Schipani E, Juppner H, Erben RG, Lanske B. Partial rescue of PTH/PTHrP receptor knockout mice by targeted expression of the Jansen transgene. Endocrinology 142: 5303-5310, 2001.
36. Stergiou GS, Zourbaki AS, Efstathiou SP, Stathopoulos GP, Keramo-poulos AD, Mountokalakis TD. Effect of estrogen receptor modulator tamoxifen on blood pressure, plasma renin activity, and renal sodium excretion. Am J Hypertens 15: 739-742, 2002.
37. Stewart AF, Wu T, Goumas D, Burtis WJ, Broadus AE. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and para-thyroid hormone-unlike domains. Biochem Biophys Res Commun 146: 672-678, 1987.
38. Sutliff RL, Weber CS, Qian J, Miller ML, Clemens TL, Paul RJ. Vasorelaxant properties of parathyroid hormone-related protein in the mouse: evidence for endothelium involvement independent of nitric oxide formation. Endocrinology 140: 2077-2083, 1999.
39. Trizna W, Edwards RM. Relaxation of renal arterioles by parathyroid hormone and parathyroid hormone-related protein. Pharmacology 42: 91-96, 1991.
40. Wendling O, Bornert JM, Chambon P, Metzger D. Efficient temporally-controlled targeted mutagenesis in smooth muscle cells of the adult mouse. Genesis 47: 14-18, 2009.
41. Wolzt M, Schmetterer L, Dorner G, Zelger G, Entlicher J, Kapiotis S, Eichler HG. Hemodynamic effects of parathyroid hormone-related peptide-(1-34) in humans. J Clin Endocrinol Metab 82: 2548-2551, 1997.
42. Wysolmerski JJ, Philbrick WM, Dunbar ME, Lanske B, Kronenberg H, Broadus AE. Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development 125: 1285-1294, 1998.